2022-04-04

NJBIZ Conversations: Chris Beddard

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD

Chris Beddard is the Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD.

In this interview with NJBIZ, she speaks about the BD Onclarity™ HPV Assay, an HPV test with extended genotyping that holds the promise of improved outcomes. As long as women use it.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
Cervical Cancer | Webinars & Videos
ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease
Cervical Cancer | News & Updates
Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease